Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials
Asthma biologics reduce exacerbations and hospitalisations, improve lung function, asthma control and quality of life, and limit the use of systemic corticosteroids, with a favourable safety profile, notably in patients with T2 inflammation. https://bit.ly/3Ijs1OQ